Neuronetics to Present at The JMP Securities Life Sciences Conference
June 03 2021 - 8:00AM
Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical
technology company focused on designing, developing and marketing
products that improve the quality of life for patients who suffer
from psychiatric disorders, today announced that Keith Sullivan,
President and Chief Executive Officer, and Steve Furlong, Senior
Vice President, Chief Financial Officer, and Treasurer, will
participate at The JMP Securities Life Sciences Conference. The
Company is scheduled to present on Thursday, June 17, 2021 at
10:00am ET.
A live audio webcast of the presentation will be available
online at the investor relations page of the Company’s website at
ir.neuronetics.com. A replay of the webcast will be archived on the
website for approximately 90 days.
About Neuronetics
Neuronetics, Inc. is a commercial-stage medical technology
company focused on designing, developing, and marketing products
that improve the quality of life for patients who suffer from
psychiatric disorders. Its commercial product, the NeuroStar®
Advanced Therapy System, is a non-invasive and non-systemic
office-based treatment that uses transcranial magnetic stimulation,
or TMS, to create a pulsed, MRI-strength magnetic field that
induces electrical currents designed to stimulate specific areas of
the brain associated with mood. The system is cleared by the United
States Food and Drug Administration, or FDA, for the treatment of
major depressive disorder in adult patients who have failed to
achieve satisfactory improvement from prior antidepressant
medication in the current episode. NeuroStar is also available in
other parts of the world, including Japan, where it is listed under
Japan’s national health insurance. Additional information can be
found at www.neuronetics.com.
Investor Contact:
Mike Vallie or Mark KlausnerWestwicke Partners443-213-0499
ir@neuronetics.com
Media Contact:
Chelsey MankoVault
Communications610-455-2778cmanko@vaultcommunications.com
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Apr 2023 to Apr 2024